Boryung Completes Phase 2 Trial Enrollment
Predicted impact: Low
Phase 2 trial enrollment milestone, routine for a drug developer and no size given.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.